title: Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
authors: Jane Anne Nohl Division of Hematology, Los Angeles, CA, United States of America.
authors: Preeti
authors: P
authors: Chaudhary
authors: Jane Anne Nohl Division of Hematology, Los Angeles, CA, United States of America.
authors: Mehmet
authors: M
authors: Hepgur
authors: Division of Internal Medicine Keck-USC School of Medicine, Los Angeles, CA, United States of America.
authors: Sarmen
authors: S
authors: Sarkissian
authors: Department of Internal Medicine, University of Iowa School of Medicine, Iowa City, IA, United States of America.
authors: Richard J H
authors: RJ
authors: Smith
authors: Jane Anne Nohl Division of Hematology, Los Angeles, CA, United States of America.
authors: Ilene C
authors: IC
authors: Weitz
mesh_terms: D000328:Adult; D065766:Atypical Hemolytic Uremic Syndrome; D001798:Blood Proteins / Q000235:genetics*; D003180:Complement C3b Inactivator Proteins / Q000235:genetics*; D017242:Complement Factor H / Q000235:genetics*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D017354:Point Mutation
chemical_list: D001798:Blood Proteins; C517621:CFHR1 protein, human; C586681:CFHR2 protein, human; C105970:CFHR3 protein, human; D003180:Complement C3b Inactivator Proteins; D017242:Complement Factor H